BridgeMD
New treatment option for BCAA
Official title TIPS With or Without BCAA
ClinicalTrials.gov ID: NCT07281846
What this study is testing
- What it's testing
- Cirrhosis is a major global cause of morbidity and mortality in chronic liver disease patients, accounting for 2.4% of global deaths in 2019. A 1990-2017 Global Burden of Disease study showed rising cirrhosis-related deaths, bringing heavy health and economic burdens.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age between 18 and 80 years old;
- Diagnosed with cirrhosis complicated by sarcopenia;
- Patients admitted due to variceal bleeding or refractory ascites who meet the indications for transjugular intrahepatic portosystemic shunt (TIPS).
You likely can't join if
- Hepatocellular carcinoma and/or other malignant tumors;
- Severe cardiopulmonary insufficiency;
- Child-Pugh score \> 13 points;
- Spontaneous recurrent hepatic encephalopathy (HE);
- Large spontaneous portosystemic shunt;
- Sepsis; spontaneous bacterial peritonitis (SBP);
See the full eligibility criteria
- Age between 18 and 80 years old;
- Diagnosed with cirrhosis complicated by sarcopenia;
- Patients admitted due to variceal bleeding or refractory ascites who meet the indications for transjugular intrahepatic portosystemic shunt (TIPS).
- Hepatocellular carcinoma and/or other malignant tumors;
- Severe cardiopulmonary insufficiency;
- Child-Pugh score \> 13 points;
- Spontaneous recurrent hepatic encephalopathy (HE);
- Large spontaneous portosystemic shunt;
- Sepsis; spontaneous bacterial peritonitis (SBP);
- Allergy to any component of the study nutritional supplement;
- High-energy and high-protein diet or use of calcium supplements, vitamin D supplements, or protein/amino acid supplements within 3 months prior to the study.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, China
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.